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Abstract
Aims
The diagnosis of stable angina involves the use of probability estimates based on clinical
presentation, age, gender and cardiovascular risk factors. In view of the link between the
cardiac and systemic vasculature we tested whether non-invasive measures of systemic
micro- and macrovascular structure and function differentiate between individuals with flow-
limiting coronary artery disease (CAD) and those with normal coronary arteries (NCA).
Methods and results
We recruited 84 patients undergoing elective coronary angiography for investigation of
symptoms of stable angina. Patients were selected for either having significant CAD or NCA
(n = 43/41; age, 56±7 vs 57±7 years, P = 0.309). Only microvascular endothelial function,
measured using the Endo-PAT2000 device to determine reactive hyperaemia index (CAD
vs. NCA; 1.9 [1.5; 2.3] vs. 2.1 [1.8; 2.4], P = 0.03) and sonographic carotid plaque score
(CAD vs. NCA; 3.0 [1.5; 4.5] vs. 1.2 [0; 2.55], P<0.001) were significantly different between
patients with CAD and NCA. No significant differences were detected in reflection magni-
tude (CAD vs. NCA; 1.7 [1.5; 1.8] % vs 1.7 [1.5; 1.9] %, P = 0.342), pulse wave velocity
(CAD vs. NCA; 7.8±1.4 m/sec vs. 8.3±1.5 m/sec, P = 0.186), carotid intima-media thickness
(CAD vs. NCA; 0.73±0.10 mm vs. 0.75±0.10 mm, P = 0.518) or carotid distensibility (CAD
vs. NCA; 3.8±1.2 10-3/kPa vs. 3.4±0.9 10-3/kPa, P = 0.092). Also, the c-statistic of the
pre-test probability based on history and traditional risk factors (c = 0.665; 95% CI, 0.540–
0.789) was improved by the addition of the inverse RHI (c = 0.720; 95% CI, 0.605–0.836),
carotid plaque score (c = 0.770, 95% CI, 0.659–0.881), and of both markers in combination
(c = 0.801; 95% CI, 0.701–0.900).
Conclusion
There are distinct differences in the systemic vasculature between patients with CAD and
NCA that may have the potential to guide diagnostic and therapeutic decisions. Carotid
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artery plaque burden and microvascular function appear to be most promising in this
context.
Introduction
Stable angina is a common disorder with an estimated prevalence of 2–4% in the Western
world [1]. In patients describing symptoms suggestive of stable angina probability estimation
is used to triage further diagnostic procedures [1,2]. This pre-test probability is usually based
on the type of chest pain, age and gender [3], but can be further adjusted with resting ECG
findings and cardiovascular risk factors [4,5]. Refining coronary artery disease (CAD) estima-
tion could reduce the number of false positive stress test results and consecutively minimise
the number of potentially harmful invasive investigation by exclusion of patients with pre-test
probability such as<5% [1] or <15% [2] from further testing. Differences in systemic vascular
markers between patients with/without CAD are well established [6–14]. Several cohort stud-
ies that assessed carotid intima-media thickness (C-IMT) and plaque [7–11] or endothelial
function [12–14] suggested a potential role for these tests in improving CAD risk stratification.
Most studies, however, have not systematically assessed a range of functional and structural
markers in small and large vessels simultaneously. A large number of tests and devices are
available for the assessment of the systemic vasculature [6]. Their value in risk prediction and
especially in CAD estimation is subject to debate. We chose to assess six markers in order to
obtain a snapshot of functional and structural properties of the systemic circulation in the
development of cardiovascular disease [15].
Material and methods
The study was designed as a two-step approach (S1 Fig). The primary aim was to identify vas-
cular markers differentiating between chest pain patients with flow-limiting CAD and normal
coronary arteries (NCA) and emerging from these results the investigation of their potential
contribution to probability estimation. The secondary aim was to assess their potential to
refine the estimation of post- (stress) test probability.
The study recruitment has been described in detail elsewhere [16] and is summarized in S1
Fig. Local cardiologists referred patients (n = 2045) with angina symptoms and/or positive
non-invasive tests to the Golden Jubilee National Hospital, Clydebank, UK for elective coro-
nary angiography between January 2009 and August 2010. We selected retrospectively those
with significant CAD, defined as a luminal obstruction of the left main stem50% and/or at
least one coronary artery stenosis75% of the remaining coronary artery lumen; or NCA,
defined as the absence of artery narrowing on coronary angiography for non-cardiac vascular
assessment. Information regarding the results of coronary angiography was retrieved from a
local database, where the degree of atherosclerosis was evaluated visually by the cardiologist
performing the angiography. Study visits took place an average of 285 (58 to 459) days after
coronary angiography.
Basic assessment during the study visit included clinical and demographic data. Informa-
tion regarding cardiovascular risk factors was acquired from interviews, medical records or
direct measurements. In this context, hypertension was defined as blood pressure140/90
mmHg on two occasions, treatment with at least one antihypertensive drug, or history of
hypertension according to medical records and/or the study visit interview. Hyperlipidaemia
was defined as either fasting cholesterol of5.5 mmol/l and/or a written or verbal history of
Non-cardiac vasculature and stable angina
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hyperlipidaemia. Blood samples were analyzed for cholesterol levels at the study visit. Diabetes
was defined in accordance with medical records or self-reporting during the study visit. Cur-
rent smoking status was considered positive when study participants smoked during the week
prior to the study visit. A positive family history was defined as prevalence of symptomatic
CAD in at least one 1st degree family member.
All participants gave written informed consent. The study was approved by the West of
Scotland Research Ethics Committee and is in keeping with the principles of the Declaration
of Helsinki.
Endothelial function was assessed non-invasive and non-pharmacological with periph-
eral arterial tonometry (PAT) performed with the Endo-PAT2000 device (Itamar Medical
Ltd., Caesarea, Israel). Blood pressure and heart rate were measured 3 times with 2-minute
intervals before the examination. The mean of the last 2 recordings was used as the baseline
blood pressure and heart rate. Beat-to-beat finger volume changes were captured by single-
use plethysmographic finger cuffs on the index fingers of both hands. After an equilibration
period of at least 5 minutes to assess the baseline PAT signal a blood pressure cuff (Hokan-
son SC12, Bellevue, USA) was inflated to at least 200 mmHg or pressures 60 mmHg above
the systolic blood pressure for exactly five minutes on the upper right arm. To ascertain that
the brachial artery was completely occluded, the on screen scale of the PAT signal was
increased to maximum amplitude. The cuff pressure was then released and the hyperaemia
PAT signal was recorded, as shown in Fig 1. Measurement from the contra-lateral arm were
used to control for changes in vascular tone. The digital pulse amplitude was continually
obtained and digitally recorded to a laptop. The data was analyzed by a a computerized algo-
rithm, which operator independent and automatically calculates the reactive hyperaemia
index (RHI). The RHI represents the ratio between the PAT signal after hyperaemia and at
baseline adjusted for the control finger. The corresponding equation is illustrated in Fig 1.
To avoid interference of factors such as outside temperature, physical activity, drug intake
and smoking, recordings were performed in a temperature controlled room at 23–24˚C,
after 20 minutes of rest in supine position. Participants were fasted and refrained from
smoking for at least 2 hours.
Following we will briefly describe the five remaining non-invasive, non-pharmacological
vascular measurements. All tests, including endothelial function assessment, were conducted
during a single study visit within a time frame of approximately 120 minutes and under identi-
cal environmental conditions. The order of investigations was as follows: electrocardiogram
(not reported), pulse wave velocity, pulse wave analysis, and endothelial function in one room
followed or proceeded by carotid ultrasound in another room. Further detail is provided in the
supplementary material (S1 File and S2–S4 Figs).
Radial arterial pressure waveforms were recorded with a Millar piezo-resistive pressure
transducer (Millar SPT 301, Millar Instruments, Houston, US) coupled to a SphygmoCor
device (AtCor Medical, Sydney, Australia). The corresponding central (ascending aortic)
waveform was generated by the SphygmoCor software (version 7.0).
To quantify the maximum of the forward and backward pressure waves in the aortic root
the triangulation method as reported by Westerhof et al. [18] was used based on central pres-
sure curve produced by the SphygmoCor device. To adjust for pressure wave extent reflection
magnitude was calculated as the ratio of the backward and forward pressure amplitudes.
Carotid femoral pulse wave velocity (PWV) was measured using the SphygmoCor device
according to the manufacturer’s protocol. Further detail can be found in the S1 File.
Measurement of C-IMT was performed by ultrasonography (Acuson Sequoia C512, Sie-
mens, Erlangen, Germany) with an 8 MHz linear-array transducer, in accordance with the
Mannheim consensus [19]. Offline measurements were performed semi-automatically at end
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diastole on B-mode images using Image-Pro Plus software, version 3.0 (Media Cybernetics,
Bethesda, USA).
Offline B-mode common carotid artery images were assessed for plaque presence and
extent in correspondence with the Mannheim consensus [19] Plaque score was then calculated
as described by Hollander et al. [20] and van der Meer et al. [21] (S2 Fig).
Fig 1. Illustration of reactive hyperaemia peripheral arterial tonometry (PAT). Depicted are a
measurement (A) with colour-coded intervals corresponding to parameters required for the reactive
hyperaemia index equation (B). Tracings derive from beat-to-beat finger volume changes captured by
plethysmographic finger cuffs on the index fingers of both hands. The interval 60–120 seconds post cuff
release is best linked to coronary microvasculature dysfunction as published by Bonnetti et al. [17].
Additionally the comparison of a pathologic (C) and a normal (D) hyperaemia responses as recorded by
fingertip plethysmography is shown. RHI, reactive hyperaemia index.
https://doi.org/10.1371/journal.pone.0178412.g001
Non-cardiac vasculature and stable angina
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Diameter changes in the common carotid arteries during the cardiac cycle were recorded to
assess carotid distensibility via M-mode imaging and were measured offline with Image-Pro
Plus software, version 3.0 (Media Cybernetics, Bethesda, USA). The average of the left and
right common carotid artery measurements was used for calculation of the distensibility coeffi-
cient (S3 Fig).
Results from exercise tolerance tests (n = 75) and myocardial perfusion single-photon emis-
sion computed tomography scans (n = 10) prior to coronary angiography were extracted from
medical records. Exercise tolerance testing following the standard Bruce protocol was per-
formed on locally available treadmills at different hospitals in Glasgow. A positive exercise test
result was defined in accordance with clinical guidelines [22].
Data were analysed using SPSS software, version 21.0 (IBM Corp., Armonk, USA). Normal-
ity of data distribution was determined using the Kolmogorov-Smirnov test and visual inspec-
tion of Q-Q plots. The two-sample Student’s t test or the Mann Whitney U-test were conducted
as appropriate for comparison of continuous variables between groups. For comparison of cate-
gorical data the Chi-squared test was employed.
The algorithm developed by Pryor et al. [4,5] was used to estimate pre-test probability of
flow-limiting CAD (S1 File). As defined by the Bayesian theory, the post-test likelihood of
flow-limiting CAD after a functional test is heavily influenced by the pre-test probability esti-
mate. Therefore the post-test probabilities were calculated multiplying the pre-test probability
with likelihood ratios [23]. The latter were computed with published test sensitivities and spec-
ificities [24].
Other reported pre-test probability estimates were derived from synoptical tables published
by Diamond and Forrester [3], Fihn et al. [1], and Genders et al. [4–5], which reference angina
typology, age and gender.
A stepwise binary logistic regression model for the prediction of CAD was used to calculate
the positive predictive value of different micro- and macrovascular parameters in combination
with pre- and post-test probabilities. The presence/absence of CAD was used as the outcome
variable and1 vascular markers plus pre- or post-test probabilities as independent variables.
Receiver operating characteristic (ROC) curves were drawn using the resulting predictive val-
ues. Such ROC curves depict the performance of a binary classifier system while its discrimina-
tory threshold is varied and where each point represents a sensitivity/specificity pair for a
particular threshold value.
Results
Based on the study inclusion criteria both subgroups were well matched for anthropometric
features and cardiovascular risk profiles, as shown in Table 1. The gender mismatch relates to
disease prevalence and contributed significantly to CAD estimation [4,5] and consecutively to
post-test probability values. Evaluation of the pre-test probability according to symptoms, age
and gender [10] showed that most patients were in the high or intermediate CAD estimate
categories.
Differences in medication between the groups were due to the retrospective nature of the
study, as well as therapeutic indication in patients with confirmed CAD [1,2]. Therefore
patients with CAD were more frequently treated with statins and anti-anginal medication.
Exercise tolerance test results were available for 75 participants. According to current diag-
nostic criteria 46 participants had positive results (27:19, CAD vs. NCA) [22]. Myocardial
perfusion single-photon emission computed tomography scans showed inducible perfusion
defects in five additional patients with NCA. There was no significant difference in positive
functional stress tests between the two groups (CAD:NCA, 27:12 vs. 24:14, P = 0.573).
Non-cardiac vasculature and stable angina
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However the calculation of post-test probabilities revealed a significant difference (CAD:NCA;
1.55±1.05 vs. 0.94±0.79, P = 0.005).
Carotid plaque score (CAD:NCA, n = 41:37; 3.0 [1.5; 4.5] vs. 1.2 [0; 2.55], P<0.001) was the
only significantly different macrovascular marker between the CAD and NCA groups (Fig
2B). Markers of arterial stiffness such as carotid distensibility (CAD vs. NCA; 3.8±1.2 10-3/kPa
vs. 3.4±0.9 10-3/kPa, P = 0.092) and pulse wave velocity (CAD vs. NCA; 7.8±1.4 m/sec vs. 8.3
±1.5 m/sec, P = 0.186); or of generalized atherosclerosis such as C-IMT (CAD vs. NCA; 0.73
±0.10 mm vs. 0.75±0.10 mm, P = 0.518) were not significantly different (Fig 1). Other macro-
vascular markers are listed in S1 Table.
Microvascular assessment showed a significant difference in endothelial function where
RHI values in NCA patients were indicative of a healthier endothelium (CAD vs. NCA; 1.9
[1.5; 2.3] vs. 2.1 [1.8; 2.4], P = 0.03) (Fig 2C). This finding persisted when only patients with
Table 1. Demographic data and angina history.
CAD (n = 43) NCA (n = 41) P-Value
Gender, m/f 26/17 13/28 0.008
Age, y 55.7±7.0 57.2±7.1 0.309
Height, cm 167±8 167±12 0.923
Weight, kg 78±14 78±23 0.945
BMI, kg/m2 28.1±4.1 27.8±6.6 0.839
WHR 0.91±0.08 0.92±0.07 0.763
SBP, mmHg 136±19 137±18 0.779
DBP, mmHg 78±10 81±9 0.282
ACEI, % 44 29 0.155
CCB, % 28 26 0.912
BB, % 91 22 <0.001
Statin, % 91 49 <0.001
Fibrates, % 2 0 -
Diabetes, % 23 17 0.280
Hypertension, % 65 59 0.615
Hyperlipidaemia, % 46 54 0.497
Positive family history, % 74 68 0.534
Current Smoker, % 28 17 0.516
Stroke/TIA, % 0 0 -
Typical angina, % 70 59 0.529
Atypical angina, % 26 29 0.933
Nonanginal chest pain, % 4 12 0.434
Probability estimate categories (Diamond/Forrester) [3] 0.479
>90%, n 23 15
10–90%, n 17 22
<10%, n 2 3
<5%, n 1 1
Probability of flow limiting CAD (Pryor et al.) [4,5] 0.69 [0.55;0.89] 0.53 [0.27;0.67] <0.001
Pre-test Likelihood of flow limiting CAD (Combined Diamond/Forrester and CASS data) [1], % 68.23±27.06 59.66±28.68 0.179
Pre-test Likelihood of flow limiting CAD (Genders et al.) [5,25], % 54.21±23.58 43.90±21.58 0.040
ACEI, Angiontensin converting enzyme inhibitor; BB, beta blocker; CAD, coronary artery disease; BMI, body mass index; CCB, calcium channel blocker;
DBP, diastolic blood pressure; ESC, European Society of Cardiology; f, female; m, male; NCA, normal coronary arteries; SBP, systolic blood pressure; TIA,
transitory ischaemic attack; vasoactive substance, summary of nicorandil, oral nitrate and CCB therapy; WHR, waist-to-hip ratio.
https://doi.org/10.1371/journal.pone.0178412.t001
Non-cardiac vasculature and stable angina
PLOS ONE | https://doi.org/10.1371/journal.pone.0178412 May 25, 2017 6 / 14
positive stress tests were investigated (CAD vs. NCA; 1.9 [1.6; 2.3] vs. 2.1 [2.0; 2.5], P = 0.02).
Resistance vessel function assessed by the reflection magnitude (CAD vs. NCA; 0.60±0.08 vs.
0.58±0.09, P = 0.342) was however not significantly different.
The majority of participants underwent assessments of endothelial function, carotid plaque
score, pre-test probability (n = 73) and post-test probability (n = 67). ROC analysis for estima-
tion of pre-test probability (c = 0.665; 95% CI, 0.540–0.789) was improved by the addition of
the inverse RHI (c = 0.720; 95% CI, 0.605–0.836), carotid plaque score (c = 0.770, 95% CI,
0.659–0.881), and of both markers in combination (c = 0.801; 95% CI, 0.701–0.900) (Fig 3A).
Similarly, ROC analysis for estimation of post-test probability (c = 0.617; 95% CI, 0.487–0.753)
was improved by the addition of the inverse RHI (c = 0.737; 95% CI, 0.617–0.857), of the
carotid plaque score (c = 0.745; 95% CI, 0.626–0.864) and of both markers (c = 0.800; 95% CI
0.694–0.907) (Fig 3B). The inverse RHI was used to adjust for the negative correlation of index
values with endothelial function. In logistic regression analyses the combination of RHI and
carotid plaque score in addition to pre- (pre-test probability/plaque score/RHI; χ2 = 20.8571,
df = 3, P = 0.0001; B = 1.6087/0.6056/-1.2366, P = 0.1904/0.0019/0.0280, SE = 1.2284/0.1951/
Fig 2. Non-cardiac vascular markers in patients with angina like symptoms and CAD or normal
coronary arteries. Illustrated are carotid IMT (A), plaque score (B), reactive hyperaemia index (C), reflection
magnitude (D), pulse wave velocity (E) and carotid distensibility (F). The continuous lines represent the mean
±SD (————) and the dotted lines represent the median + interquartile range (— — —). CAD, coronary
artery disease; NCA, normal coronary arteries; IMT, carotid intima media thickness; RHI, reactive hyperaemia
index; PWV, pulse wave velocity; DC, distensibility coefficient; ns, non-significant.
https://doi.org/10.1371/journal.pone.0178412.g002
Non-cardiac vasculature and stable angina
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0.5626, OR = 4.9962/1.8323/ 0.2904) or post-test probabitity (post-test probability/plaque
score/RHI; χ2 = 19.6582, df = 3, P = 0.0002; B = 0.3685/0.5859/-1.6280, P = 0.2477/0.0033/
0.0114, SE = 0.3188/ 0.1992/0.6436, OR = 1.4456/1.7966/0.1963) contributed significantly to
the prediction of CAD.
Considering the plaque score distribution in Fig 2B, we calculated the test characteristics
for carotid plaque vs. no carotid plaque in our cohort (CAD vs. NCA; plaque detected/no pla-
que, n = 37/4 vs. n = 19/18, P<0.001; Positive Predictive Value = 66%, Negative Predictive
Value = 82%, Sensitivity = 90%, Specificity = 49%).
Discussion
The study addressed the potential role of comprehensive systemic vascular assessment in
patients presenting with symptoms suggestive of stable angina. Micro- and macrovascular
structure and function relate to intermediate steps of cardiovascular disease progression [15].
In fact, with ageing, hypertension, cardiac and renal disease alterations in small and large
arteries are now understood to be closely interrelated in a self-perpetuating cycle of remodel-
ling and vascular damage [26]. We systematically evaluated these processes using validated
clinical vascular markers as illustrated in Fig 4. Carotid plaque extent or microvascular endo-
thelial function differentiated between patients with CAD and NCA in our study cohort. We
have however not found any differences in reflection magnitude as well as the macrovascular
parameters pulse wave velocity, C-IMT and carotid distensibility, between the two groups.
The latter macrovascular markers, despite their relation to intermediate steps of cardiovas-
cular disease [15], lack discriminatory capacity in our cohort. This finding most likely relates
to the similarity of traditional cardiovascular risk factors in CAD and NCA patients of our
cohort. In particular blood pressure and age, two of the major determinants of C-IMT and
arterial stiffness [26], were evenly distributed. We therefore assume that cardiovascular disease
progression had only a small, non-detectable effect on these markers, explaining our finding.
Reports on microvascular endothelial function as measured by the RHI to identify CAD in
cohorts of different origin showed ambiguous results [12–14]. RHI has been linked to different
Fig 3. ROC-analysis for CAD estimation. Depicted are ROC-curves for pre- (A) and post-test probability (B)
and added vascular markers. RHI-1, inverse reactive hyperaemia index.
https://doi.org/10.1371/journal.pone.0178412.g003
Non-cardiac vasculature and stable angina
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processes leading to angina symptoms, in particular cardiac microvascular dysfunction and
cardiac macrovascular endothelial dysfunction [12], a precursor of atherosclerosis. Invasive
assessment of the coronary microcirculation comes with the costs and risks associated with
angiography. Migration of these techniques to the peripheral circulation with non-invasive
methods enables repeated evaluation of measurements thought to closely mirror coronary
artery microvascular function [17]. Patients with NCA and an abnormal stress test response
often suffer from cardiac microvascular dysfunction [27], which is often associated with more
widespread systemic microvascular disease [28]. In our study, however, we observed worse
RHI values in the CAD patients with positive functional test compared to the NCA group.
Although patients with NCA and a positive functional test can suffer from cardiac microcircu-
latory dysfunction [12], the difference in non-cardiac microvascular endothelial function was
sufficient to differentiate between patients with CAD and NCA in our study. It therefore
appears that the magnitude of endothelial dysfunction in CAD patients is greater than in NCA
patients consistent with published literature [13]. In addition it should be borne in mind that
NCA patients with angina symptoms represent a quite heterogeneous group [12].
Fig 4. Markers in the cardiovascular continuum. The inner circle (yellow) states the stage of the
cardiovascular continuum. The middle circle (blue) states the different pathophysiological process or
categorises of the cardiovascular continuum stage. The outer circle (black) summarises a range of markers
quantifying the pathophysiological process. Investigated markers (bold & italic) capable of differentiating
between patients with CAD and NCA in our study are highlighted red. Investigated markers (bold & italic)
without statistical significant differences between patients with CAD and NCA are highlighted orange. SNP,
single nucleotide polymorphism; CRP, C-reactive protein; IL-6, interleukin 6; TNFα, tumour necrosis factor α;
ICAM-1, intercellular adhesion molecule-1; LDL, low density lipoprotein; RH-PAT, reactive hyperaemia pulse
amplitude tonometry; EPCs, endothelial progenitor cells; IMT, intima media thickness; ABI, ankle brachial
index; LVH, left ventricular hypertrophy; ECG, electrocardiography; ACS, acute coronary syndrome; CAD,
coronary artery disease; NCA, normal coronary arteries; TIA, transitory ischaemic attack; CT, computer
tomography; MRI, magnet resonance imaging; GFR, glomerular filtration rate; BNP, brain natriuretic peptide.
Adapted from Dzau et al. [15].
https://doi.org/10.1371/journal.pone.0178412.g004
Non-cardiac vasculature and stable angina
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Atherosclerosis is a systemic disease where carotid and coronary artery plaque coincide.
Not only are plaque characteristics similar in both arterial beds [29], but carotid plaque and
CAD extent [30] as well as CAD complexity [9] also correlate. Unsurprisingly, the presence of
carotid plaque differentiated chest pain patients referred for coronary angiography with CAD
from those with NCA in several cohort studies [7–11]. Consequently the European Society of
Cardiology recommends carotid ultrasound in chest pain patients without known atheroscle-
rotic disease [2]. However, similar to cohort studies investigating RHI [12–14], these studies
did not assess the marker’s additive value to guideline conform assessment of pre-test proba-
bility [1,2] and were limited to a single aspect of the cardiovascular continuum.
Probability estimation is not only critical to implement a proper diagnostic work-up but
also to improve the yield of diagnostic tests. For instance, our cohort had an average CAD like-
lihood of 64% according to the combined Diamond/Forrester and CASS data [1]. Exercise
tolerance testing, with a sensitivity of 68% and a specificity of 77% [24], would produce a diag-
nostic yield of 84% (True Positive/ All Positives Test Results) in our cohort. In this setting a
10% increase of probability estimates through exclusion of NCA patients with<5% [1] or
<15% [2] CAD likelihood from stress testing would provide a 5% increase in diagnostic yield.
Several methods for determination of pre-test probability have been described [1,2]. In our
cohort only the algorithm by Pryor et al. [4,5] and the table by Genders et al. [2,25] showed sta-
tistical significant differences between CAD and NCA patients. According to the combined
Diamond/Forrester and CASS data [1] our cohort had a CAD likelihood of 68% in the CAD
group and 60% in the NCA group meaning that 32% or 60% of patients were incorrectly allo-
cated. More sensitive means for identification of individuals with symptomatic CAD could
therefore inform further diagnostic testing and prevent unnecessary invasive procedures.
In this study, the addition of RHI, carotid plaque score or their combination to an estab-
lished pre-test probability algorithm [4,5] increased the c-statistic by 0.055, 0.105 and 0.136,
respectively. Also, the combination of RHI and carotid plaque score in addition to pre-test
probability values contributed significantly to logistic regression models predicting CAD. We
therefore provided evidence that these measurements have the potential to improve CAD
probability estimation. Also, assessment of carotid plaque, in particular absence of such with a
negative predictive value of 80–81% in the literature [7,11] and 82% in our cohort, probably
represents the best approach to pre-test probability improvement in clinical practice as a “rule-
out test” due to its low cost, repeatability and wide availability.
The addition of RHI, carotid plaque score or their combination to the post-test probability
value, based on pre-test probability [4,5] and stress test modality/result, increased the c-statis-
tic by 0.120, 0.128 and 0.183, respectively. The approach produced results at least similar to
pre-test probability estimations in our cohort and provides a feasible strategy to improve diag-
nostic yield in patients referred for coronary angiography.
Due to the retrospective study design patients differed from their first cardiology assess-
ment in terms of medical management, percutaneous coronary intervention, exercise capacity
and lifestyle modifications. As luminal obstruction of the left main stem50% and/or at least
one coronary artery stenosis75% of the remaining coronary arteries as seen on coronary
angiography was the inclusion criteria for patients with CAD, we also did not address the rela-
tionship between endothelial function or carotid plaque and non-flow limiting CAD. Previous
studies have however shown similar RHI in patients with hemodynamically significant and
non-significant coronary lesions [12] and in the iPOWER study investigating 339 middle aged
to elderly women with angina symptoms and non-flow limiting CAD the use of the cut-off
value RHI = 2.0 [31] lead to a similar sensitivity and specificity as in our study, 56% and 61%
vs. 58% and 52%, respectively. Carotid plaque, however, occurs in obstructive and non-
obstructive CAD, although more often in the former [11]. Also our study and others [8–14]
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only investigated patients referred for coronary angiography. A large percentage of patients
presenting with chest pain, such as patients with low CAD likelihood or negative stress test
results are therefore excluded from the analysis resulting in a degree of selection bias.
Conclusions
Changes in both the systemic macro- and microcirculation are evident in patients with angina
symptoms in whom CAD is confirmed at angiography. We identified carotid plaque and
microvascular endothelial function as markers capable of differentiating patients who are
found to have CAD from those with NCA. Both markers, alone or in combination, have the
potential to improve pre- and post-test probability assessment for angiographyically significant
CAD.
Supporting information
S1 Fig. Flowchart of the study design and recruitment process. CAD, coronary artery dis-
ease; NCA, normal coronary arteries; PWA, pulse wave analysis; SPECT, single positron emis-
sion computer tomography; EndoPAT, Endo-PAT2000 device (Itamar Medical Ltd., Caesarea,
Israel).
(TIF)
S2 Fig. Illustration of the used carotid plaque score. Areas with plaque burden are
highlighted with arrows in B-mode common carotid artery images (A). The carotid plaque
definition according to the Mannheim carotid IMT consensus is listed (B). The carotid plaque
score equation is shown in C. Regarding the carotid pictures in panel A this leads to a carotid
plaque score of 4.8 (number of affected vessel segments: 4, number of visualised vessel seg-
ments: 5).
(TIF)
S3 Fig. Illustration of the distensibility coefficient. Depicted are relevant measurements on
M-mode images of the common carotid artery (A) and the distensibility coefficient equation
(B) as well as Cross-sectional B-mode image of the common carotid artery (C) in systole (left
side) and diastole (right side). DC, distensibility coefficient; Dd, diastolic diameter; Ds, systolic
diameter; SBP, systolic blood pressure; DBP, diastolic blood pressure.
(TIF)
S4 Fig. Calculation of aortic forward and backward pressure waves. The central pulse wave
and a corresponding triangular aortic flow wave [18] are shown in A. Equations for calculation
of forward and backward pressure waves are given (A). B illustrates an aortic flow wave with
corresponding forward and backward pressure waves. cPP, central pulse pressure; ESp, end-
systolic pressure; P1, pressure at T1; Pf, forward pressure wave; Pb, backward pressure wave;
Zc, aortic characteristic impedance; F, flow; T1, time at first inflection point; ED, time point
marking the start of diastole (early diastole).
(TIF)
S1 Table. Additional non-cardiac vascular markers. AIx, augmentation index; CAD, coro-
nary artery disease; cDBP, central diastolic blood pressure; cPP, central pulse pressure; cSBP,
central systolic blood pressure; NCA, normal coronary arteries; pPP, peripheral pulse pressure.
(PDF)
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